Nutrients (Sep 2022)

Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution—A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI)

  • Jürgen Harreiter,
  • Lilian C. Mendoza,
  • David Simmons,
  • Gernot Desoye,
  • Roland Devlieger,
  • Sander Galjaard,
  • Peter Damm,
  • Elisabeth R. Mathiesen,
  • Dorte M. Jensen,
  • Lise Lotte T. Andersen,
  • Fidelma Dunne,
  • Annunziata Lapolla,
  • Maria G. Dalfra,
  • Alessandra Bertolotto,
  • Ewa Wender-Ozegowska,
  • Agnieszka Zawiejska,
  • David Hill,
  • Judith G. M. Jelsma,
  • Frank J. Snoek,
  • Christof Worda,
  • Dagmar Bancher-Todesca,
  • Mireille N. M. van Poppel,
  • Rosa Corcoy,
  • Alexandra Kautzky-Willer,
  • on behalf of the DALI Core Investigator Group

DOI
https://doi.org/10.3390/nu14183781
Journal volume & issue
Vol. 14, no. 18
p. 3781

Abstract

Read online

Vitamin D deficiency is a common finding in overweight/obese pregnant women and is associated with increased risk for adverse pregnancy outcome. Both maternal vitamin D deficiency and maternal obesity contribute to metabolic derangements in pregnancy. We aimed to assess the effects of vitamin D3 supplementation in pregnancy versus placebo on maternal and fetal lipids. Main inclusion criteria were: women 2. Eligible women (n = 154) were randomized to receive vitamin D3 (1600 IU/day) or placebo. Assessments were performed p = 0.012). Vitamin D supplementation in pregnancy increases maternal and cord blood vitamin D significantly resulting in high rates of vitamin D sufficiency. Maternal and cord blood lipid parameters were unaffected by Vitamin D3 supplementation.

Keywords